Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes - Rossi - 2020

Frontiers Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study

Irritable bowel syndrome - Wikipedia

Albert JERGENS, DVM, MS, PhD, DACVIM, Iowa State University, IA, ISU, Department of Veterinary Clinical Sciences

Neonatal intestinal dysbiosis

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Frontiers Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review

Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review - ScienceDirect

Cannabinoids and the Gastrointestinal Tract - Clinical Gastroenterology and Hepatology

Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes